Raphael Pharmaceutical (RAPH) Non-Current Assets (2022 - 2026)

Raphael Pharmaceutical has disclosed Non-Current Assets across 5 years of filings, most recently posting $1000.0 for Q2 2026.

• In Q2 2026, Non-Current Assets fell 50.0% year-over-year to $1000.0; the TTM figure through Jun 2026 stood at $7000.0 (down 12.5% YoY), while the FY2025 annual figure was $2000.0, changed 0.0% from the prior year.
• Non-Current Assets came in at $1000.0 for Q2 2026 at Raphael Pharmaceutical, down from $2000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3000.0 in Q1 2024 to a low of $1000.0 in Q1 2023.
• Average Non-Current Assets over 5 years is $1800.0, with a median of $2000.0 recorded in 2022.
• Year-over-year, Non-Current Assets tumbled 50.0% in 2023 and soared 200.0% in 2024.
• Over 5 years, Non-Current Assets stood at $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025, then plunged by 50.0% to $1000.0 in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $1000.0 in Q2 2026, $2000.0 in Q4 2025, and $2000.0 in Q3 2025.